Clinical Trial Update: Smart MDI Study (CIP343) [NA]

View source ↗

Summary

A clinical trial update for the CIP343 Smart MDI study by Medtronic MiniMed indicates the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Smart MDI CIP343

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED